Findings reveal IL-13 signaling promotes inflammation and liver fibrosis in Schistosoma japonicum infection, suggesting IL-13RA2 as a therapeutic target.
the MEK/ERK pathway. Hence, IL-13RA2 may represent an effective and promising therapeutic target for the attenuation of liver fibrosis.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: